Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma.
暂无分享，去创建一个
L. Qin | C. Antonescu | S. Singer | G. Schwartz | W. Tap | M. Dickson | M. Keohan | Jonathan Landa | M. Condy | Yelena Ustoyev | Dustin D. Rathbone | Eric Gerard Dohrenwend